Article
Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease.
The New England journal of medicine - 1 Apr 2021
Mbala-Kingebeni Placide, Pratt Catherine, Mutafali-Ruffin Mbusa, Pauthner Matthias G, Bile Faustin, Nkuba-Ndaye Antoine, Black Allison, Kinganda-Lusamaki Eddy, Faye Martin, Aziza Amuri, Diagne Moussa M, Mukadi Daniel, White Bailey, Hadfield James, Gangavarapu Karthik, Bisento Nella, Kazadi Donatien, Nsunda Bibiche, Akonga Marceline, Tshiani Olivier, Misasi John, Ploquin Aurelie, Epaso Victor, Sana-Paka Emilia, N'kasar Yannick Tutu Tshia, Mambu Fabrice, Edidi Francois, Matondo Meris, Bula Bula Junior, Diallo Boubacar, Keita Mory, Belizaire Marie R D, Fall Ibrahima S, Yam Abdoulaye, Mulangu Sabue, Rimoin Anne W, Salfati Elias, Torkamani Ali, Suchard Marc A, Crozier Ian, Hensley Lisa, Rambaut Andrew, Faye Ousmane, Sall Amadou, Sullivan Nancy J, Bedford Trevor, Andersen Kristian G, Wiley Michael R, Ahuka-Mundeke Steve, Muyembe Tamfum Jean-Jacques
Abstract excerpt
During the 2018-2020 Ebola virus disease (EVD) outbreak in North Kivu province in the Democratic Republic of Congo, EVD was diagnosed in a patient who had received the recombinant vesicular stomatitis virus-based vaccine expressing a ZEBOV glycoprotein (rVSV-ZEBOV) (Merck). His treatment included an Ebola virus (EBOV)-specific monoclonal antibody (mAb114), and he recovered within 14 days. However, 6 months later,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.